Latest news with #SunilSinghania
Mint
10-07-2025
- Business
- Mint
Crizac share price rallies another 9%, now trades 32% higher than IPO price
Crizac share price in focus today: After making a bumper debut on the Indian stock market, Crizac share price extended its momentum on Thursday, rallying another 9% to hit the day's high of ₹ 334.75 apiece in intraday trade. Crizac share price made a grand entry on the exchanges on Wednesday, listing at ₹ 281.05 on the NSE, a 14.71% premium over the IPO price of ₹ 245, and ended its first trading day even higher at ₹ 307.60. Adding to the excitement on debut day, Sunil Singhania's Abakkus Asset Manager Pvt Ltd. picked up a stake in the company during the listing itself. According to exchange data, Abakkus Asset Managers bought 36.73 lakh shares at ₹ 298.33 apiece, taking the total transaction value to approximately ₹ 109.5 crore. Taking today's intraday high into account, Crizac share price has gained 37% over its IPO price.
Business Standard
10-07-2025
- Business
- Business Standard
Crizac gains after Abakkus Asset Manager picks up stake
Crizac climbed 4.86% to close at Rs 322.40 after ace fund manager Sunil Singhania's Abakkus Asset Manager picked up a stake in the company on the day it listed on the bourses. Data from the NSE shows Abakkus bought 36.73 lakh shares at Rs 298.33 apiece on Wednesday, 9 July 2025. The transaction was valued at Rs 109.57 crore. Crizac made its stock market debut at Rs 280, listing at a 14.29% premium to the issue price of Rs 245. It eventually settled at Rs 307.45 on the BSE, up 25.49% from its IPO price. The IPO was open from 2 to 4 July 2025 with a price band of Rs 233 to 245 per share. It was a pure offer-for-sale of 3.51 crore equity shares. Promoter Pinky Agarwal offloaded shares worth Rs 723 crore, while Manish Agarwal sold shares worth Rs 137 crore. Ahead of the IPO, Crizac raised Rs 10 crore from anchor investors on 1 July 2025. The company allotted 4.08 lakh shares at Rs 245 each to 19 anchor investors. Founded in 2011, Crizac is a B2B education platform offering international student recruitment solutions to universities in the UK, Canada, Ireland, Australia, and New Zealand. It works with over 10,000 registered agents and has processed more than 7.11 lakh applications from students across 75 countries, partnering with 173 global institutions. It operates in countries like Cameroon, China, Ghana, and Kenya. It had 368 employees and 12 consultants as of 31 March 2025.
&w=3840&q=100)
Business Standard
10-07-2025
- Business
- Business Standard
Crizac gains 34% in two days of listing; Abakkus Asset buys 2.1% equity
Crizac share price registered an all-time high on BSE, at ₹334.15 per share, a day after listing on the bourses. The stock extended rally for the second session and was up nearly 34 per cent. At 11:07 AM, Crizac shares were up 7.72 per cent at ₹331.2 per share on the BSE. In comparison, the BSE Sensex was down 0.34 per cent at 83,248.68. The company's market capitalisation stood at ₹5,759.55 crore. The stock got listed at ₹281.05 per share and its initial public offer (IPO) issue price was at ₹245 per share. What led to rally in Crizac a day after listing? The buying on the counter came after ace investor Sunil Singhania's Abakkus Asset Manager bought 3.67 lakh shares (2.1 per cent stake) at ₹298.33 per share of the company on the National Stock Exchange (NSE). The transaction was worth ₹1,095,876,110. Abakkus is an asset management firm primarily investing in listed Indian equities. Crizac IPO listing Shares of education-related services provider Crizac made a positive debut on Dalal Street on Wednesday, following the completion of their initial public offering (IPO). Crizac shares listed at ₹280 per share, reflecting a premium of ₹35 or 14.29 per cent over the issue price of ₹245 per share. On the NSE, Crizac shares listed at a slightly higher premium of ₹36.05 or 14.71 per cent, at ₹281.05 per share. The public issue of Crizac comprised an entirely offer-for-sale (OFS) by Manish Agarwal and Pinky Agarwal, who divested up to 35.2 million equity shares, estimated to be valued at around ₹860 crore. Crizac IPO was open for subscription from July 2 to July 4, at a price band of ₹233–₹245 per equity share, with a lot size of 61 shares. The public issue garnered strong demand among investors, getting oversubscribed by 59.82 times. This was led by Qualified Institutional Buyers (QIBs), who oversubscribed the category reserved for them by a whopping 134.35 times, according to NSE data. About Crizac Crizac is based in India, with co-primary operations in London, United Kingdom. In addition to extensive operations and employees in India, it has consultants in multiple countries including Cameroon, China, Ghana, and Kenya. It is a B2B education platform for agents and global institutions of higher education, offering international student recruitment solutions to global institutions.
Economic Times
05-06-2025
- Business
- Economic Times
Sunil Singhania picks stake in Indegene, stock up 4%
Indegene shares: Sunil Singhania's fund acquired a stake in the company via a significant block deal. Synopsis Indegene shares: Abakkus was one of several institutional investors that participated in the transaction through which private equity giant Carlyle Group fully exited its 10.2% stake in the digital healthcare company. Shares of Indegene Ltd rose as much as 3.7% to Rs 611.50 on the BSE on Thursday, a day after Sunil Singhania's Abakkus Emerging Opportunities Fund picked up a stake in the company through a large block deal. Abakkus was among several institutional investors that bought shares in the transaction where private equity major Carlyle Group exited its entire 10.2% holding in the digital healthcare firm. ADVERTISEMENT A total of 2.53 crore shares, amounting to 10.56% of Indegene's equity, changed hands on Wednesday, June 4, at an average price of Rs 591 apiece, according to exchange data released Thursday. Carlyle, through its unit CA Dawn Investments, was the sole seller in the deal, garnering Rs 1,447 crore from the divestment. Alongside Abakkus, other buyers included East Bridge Capital Master Fund, Societe Generale, Smallcap World Fund, and Premji Invest's affiliate PI Opportunities AIF V. Together, these investors picked up 1.06 crore shares, or 4.42% stake, for Rs 627 crore. The shares were acquired in the price range of Rs 591–591.48 each. Details of other buyers were not available on the National Stock Exchange as of exit marks the end of a four-year investment in Indegene. The global private equity firm had invested $122 million (Rs 917 crore) in April 2021, purchasing 4.55 crore shares at Rs 201 apiece. ADVERTISEMENT Since then, it has sold shares in phases, first during Indegene's IPO in May 2024 at Rs 452 apiece, then at Rs 618 in December 2024, and finally at around Rs 591 this week. The investment delivered an internal rate of return of 31% for Carlyle, underscoring the strong returns possible in India's digital healthcare shares had fallen 4.07% on Wednesday to Rs 594.50 following the block transaction, but rebounded on Thursday as investor interest in the stock remained firm. ADVERTISEMENT Also read | Carlyle group exits Indegene; sells 10.2% stake for Rs 1,447 crore (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel) Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains NEXT STORY
Time of India
05-06-2025
- Business
- Time of India
Sunil Singhania picks stake in Indegene, stock up 4%
Shares of Indegene Ltd rose as much as 3.7% to Rs 611.50 on the BSE on Thursday, a day after Sunil Singhania 's Abakkus Emerging Opportunities Fund picked up a stake in the company through a large block deal. Abakkus was among several institutional investors that bought shares in the transaction where private equity major Carlyle Group exited its entire 10.2% holding in the digital healthcare firm. A total of 2.53 crore shares, amounting to 10.56% of Indegene's equity, changed hands on Wednesday, June 4, at an average price of Rs 591 apiece, according to exchange data released Thursday. Carlyle, through its unit CA Dawn Investments, was the sole seller in the deal, garnering Rs 1,447 crore from the divestment. Who bought? Alongside Abakkus, other buyers included East Bridge Capital Master Fund, Societe Generale, Smallcap World Fund, and Premji Invest's affiliate PI Opportunities AIF V. Together, these investors picked up 1.06 crore shares, or 4.42% stake, for Rs 627 crore. The shares were acquired in the price range of Rs 591–591.48 each. Details of other buyers were not available on the National Stock Exchange as of Thursday. Carlyle's phased exit Carlyle's exit marks the end of a four-year investment in Indegene. The global private equity firm had invested $122 million (Rs 917 crore) in April 2021, purchasing 4.55 crore shares at Rs 201 apiece. Since then, it has sold shares in phases, first during Indegene's IPO in May 2024 at Rs 452 apiece, then at Rs 618 in December 2024, and finally at around Rs 591 this week. The investment delivered an internal rate of return of 31% for Carlyle, underscoring the strong returns possible in India's digital healthcare sector. Indegene's shares had fallen 4.07% on Wednesday to Rs 594.50 following the block transaction, but rebounded on Thursday as investor interest in the stock remained firm. Also read | Carlyle group exits Indegene; sells 10.2% stake for Rs 1,447 crore ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
